Page 82 - CPG - Clinical Practice Guidelines - Management of Cancer Pain

Management of Cancer Pain (Second Edition)

19. Tzamakou E, Petrou A, Tefa L, et al. Detection of Neuropathic Pain in End-
6WDJH &DQFHU 3DWLHQWV 'LDJQRVWLF $FFXUDF\ RI 7ZR 4XHVWLRQQDLUHV 3DLQ 3UDFW
2018;18(6):768-776.
0XUWDJK )( 5DPVHQWKDOHU & )LUWK $ HW DO $ EULHI SDWLHQW DQG SUR[\ UHSRUWHG
outcome measure in advanced illness: Validity, reliability and responsiveness
RI WKH ,QWHJUDWHG 3DOOLDWLYH FDUH 2XWFRPH 6FDOH ,326 3DOOLDW 0HG
2019;33(8):1045-1057.
+DQQRQ % '\FN 0 3RSH $ HW DO 0RGL¿HG (GPRQWRQ 6\PSWRP $VVHVVPHQW
6\VWHP LQFOXGLQJ FRQVWLSDWLRQ DQG VOHHS YDOLGDWLRQ LQ RXWSDWLHQWV ZLWK FDQFHU -
3DLQ 6\PSWRP 0DQDJH
'XQIRUG ( :HVW ( 6DPSVRQ (/ 3V\FKRPHWULF HYDOXDWLRQ RI WKH 3DLQ
Assessment in Advanced Dementia scale in an acute general hospital setting.
,QW - *HULDWU 3V\FKLDWU\
23. Bandieri E, Romero M, Ripamonti CI, et al. Randomized Trial of Low-Dose
Morphine Versus Weak Opioids in Moderate Cancer Pain. J Clin Oncol.
2016;34(5):436-442.
24. Fallon M, Dierberger K, Leng M, et al. An international, open-label, randomised
trial comparing a two-step approach versus the standard three-step approach of
the WHO analgesic ladder in patients with cancer. Ann Oncol. 2022;33(12):1296-
1303.
1DEDO 0 /LEUDGD 6 5HGRQGR 0- HW DO 7KH UROH RI SDUDFHWDPRO DQG QRQVWHURLGDO
DQWL LQÀDPPDWRU\ GUXJV LQ DGGLWLRQ WR :+2 6WHS ,,, RSLRLGV LQ WKH FRQWURO RI
pain in advanced cancer. A systematic review of the literature. Palliat Med.
2012;26(4):305-312.
'HUU\ 6 :LIIHQ 3- 0RRUH 5$ HW DO 2UDO QRQVWHURLGDO DQWL LQÀDPPDWRU\
GUXJV 16$,'V IRU FDQFHU SDLQ LQ DGXOWV &RFKUDQH 'DWDEDVH 6\VW 5HY
2017;7(7):CD012638.
:LIIHQ 3- 'HUU\ 6 0RRUH 5$ HW DO 2UDO SDUDFHWDPRO DFHWDPLQRSKHQ IRU
FDQFHU SDLQ &RFKUDQH 'DWDEDVH 6\VW 5HY &'
&DUDFHQL $ +DQNV * .DDVD 6 HW DO 8VH RI RSLRLG DQDOJHVLFV LQ WKH WUHDWPHQW RI
cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol.
2012;13(2):e58-68.
%HDNOH\ %' .D\H $0 .D\H $' 7UDPDGRO 3KDUPDFRORJ\ 6LGH (IIHFWV DQG
6HURWRQLQ 6\QGURPH $ 5HYLHZ 3DLQ 3K\VLFLDQ
:LIIHQ 3- 'HUU\ 6 0RRUH 5$ 7UDPDGRO ZLWK RU ZLWKRXW SDUDFHWDPRO
DFHWDPLQRSKHQ IRU FDQFHU SDLQ &RFKUDQH 'DWDEDVH 6\VW 5HY
CD012508.
6WUDXEH & 'HUU\ 6 -DFNVRQ .& HW DO &RGHLQH DORQH DQG ZLWK SDUDFHWDPRO
DFHWDPLQRSKHQ IRU FDQFHU SDLQ &RFKUDQH 'DWDEDVH 6\VW 5HY
CD006601.
:RUOG +HDOWK 2UJDQL]DWLRQ :HE $QQH[ $ :RUOG +HDOWK 2UJDQL]DWLRQ 0RGHO /LVW
of Essential Medicines – 23rd List, 2023. In: The selection and use of essential
PHGLFLQHV ([HFXWLYH VXPPDU\ RI WKH UHSRUW RI WKH WK :+2 ([SHUW
&RPPLWWHH RQ WKH 6HOHFWLRQ DQG 8VH RI (VVHQWLDO 0HGLFLQHV *HQHYD :+2
2023.
33. Wiffen PJ, Wee B, Moore RA. Oral morphine for cancer pain. Cochrane Database
6\VW 5HY &'
:LOFRFN $ +RZDUG 3 6 & 3DOOLDWLYH &DUH )RUPXODU\ (LJKWK (GLWLRQ /RQGRQ
Pharmaceutical Press; 2022.
6FKPLGW +DQVHQ 0 %HQQHWW 0, $UQROG 6 HW DO 2[\FRGRQH IRU FDQFHU UHODWHG
SDLQ &RFKUDQH 'DWDEDVH 6\VW 5HY &'
%LDQFR¿RUH * 2[\FRGRQH FRQWUROOHG UHOHDVH LQ FDQFHU SDLQ PDQDJHPHQW 7KHU
Clin Risk Manag. 2006;2(3):229-234.

64

e-cpg inside text-Cancer pain-25/5/24.indd 64 09/08/2024 12:09 AM